ST JUDE MEDICAL, LLC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2015 12 months to Jan 2, 2016	FY2014 12 months to Jan 3, 2015	FY2013 12 months to Dec 28, 2013	FY2012 12 months to Dec 29, 2012	FY2011 12 months to Dec 31, 2011
OPERATING ACTIVITIES
Net earnings
Net earnings before noncontrolling interest
Adjustments to reconcile net earnings before noncontrolling interest to net cash from operating activities:
Depreciation and amortization
Depreciation of property, plant and equipment
Amortization of intangible assets
Total depreciation and amortization
Amortization of debt premium, discounts and debt issue costs
Inventory step-up amortization
Contingent consideration fair value adjustments
Payment of contingent consideration
Stock-based compensation
Cash settlement of accelerated equity awards
Excess tax benefits from stock issued under employee stock plans
Investment impairment charges
Gain on sale of investments
Purchased in-process research and development charges
Loss on retirement of long-term debt
Deferred income taxes
Other, net
Changes in operating assets and liabilities, net of business combinations:
Accounts receivable
Inventories
Other current and noncurrent assets
Accounts payable and accrued expenses
Income taxes payable
Net cash provided by operating activities

INVESTING ACTIVITIES
Purchases of property, plant and equipment
Business combination payments, net of cash acquired
Proceeds from sale of investments
Other investing activities, net
Net cash used in investing activities
FINANCING ACTIVITIES
Proceeds from exercise of stock options and stock issued, net
Excess tax benefits from stock issued under employee stock plans
Common stock repurchased, including related costs
Dividends paid
Issuances (payments) of commercial paper borrowings, net
Proceeds from debt
Payments of debt
Payments of debt issue costs and commitment fees
Purchase of shares from noncontrolling ownership interest
Payment of contingent consideration
Other financing activities, net
Net cash provided by (used in) financing activities
Effect of currency exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Cash Flow Information
Income taxes
Interest
Other Significant Noncash Transaction, Value of Consideration Received

Noncash investing and financing activities:
Additions in noncontrolling ownership interests
Fair value of acquisition contingent consideration
Fair value of equity awards exchanged in business combination

Comments